Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Journal
Age
Showing 1 to 12 of 2432 entries
Sorted by: Best Match Show Resources per page
Biological activity of different calcitonins in men.

Gennari C, Gonnelli S, Agnusdei D, Civitelli R.
PMID: 2171971
Exp Gerontol. 1990;25(3):339-47. doi: 10.1016/0531-5565(90)90071-9.

Calcitonin has been isolated and its structure defined from several species, including man. Synthetic preparations of several calcitonins are available for clinical use. Of these, porcine (pCT), human (hCT), and salmon (sCT) have been synthetized according to their natural...

Successful treatment of resistant Paget's disease of bone with pamidronate.

Mallette LE.
PMID: 2596945
Arch Intern Med. 1989 Dec;149(12):2765-7.

Several agents are available for treatment of Paget's disease of bone, but their long-term use may be limited by resistance or adverse effects. I have treated two patients with exceptionally severe polyostotic Paget's disease (serum alkaline phosphatase values 25-...

Use of nasally administered salmon calcitonin in preventing bone loss.

Christiansen C.
PMID: 1933614
Calcif Tissue Int. 1991;49:S14-5. doi: 10.1007/BF02561371.

This article reviews several of our studies in which we evaluated the effect of nasal salmon calcitonin in preventing bone loss in normal women just after menopause. In the first study, after treatment with nasal salmon calcitonin, bone loss...

Use of calcitonin in the treatment of bone pain associated with osteoporosis.

Gennari C, Agnusdei D, Camporeale A.
PMID: 1933618
Calcif Tissue Int. 1991;49:S9-13. doi: 10.1007/BF02561370.

In osteoporosis, calcitonin exerts an analgesic effect that is unrelated to its effect on bone. Although the precise mechanism has yet to be clarified, there is some evidence that the analgesic effect of calcitonin may be mediated through the...

Update on endocrinology.

Marsh M, Burger HG.
PMID: 1530464
Aust Fam Physician. 1992 Apr;21(4):407-11.

Endocrinology covers diverse groups of organs and diseases. In this article, advances in the investigation of thyroid dysfunction, the management of Paget's disease of bone and the investigation and management of polycystic ovary syndrome are discussed.

Climacteric and menopause--medical point of view.

Morales Pereira A.
PMID: 2270263
P R Health Sci J. 1990 Apr;9(1):85-7.

A discussion of the problems associated with the menopause and a regime to combat its effects is described. Treatment of the psychological aspects of menopause is stressed as well as the estrogen-replacement therapy.

[Effect of thyrocalcitonin on the functions of the intact and hypertrophied myocardium].

Merzon AK, Glezer GA, Doviner AD, Briskin AI, Pesikov IaS.
PMID: 150469
Kardiologiia. 1978 Jul;18(7):86-91.

Examination of 20 individuals without any pathological conditions of the cardiovascular system and 8 patients with myocardial hypertrophy has shown that the hypocalciemic hormone of the thyroid gland thyrocalcitonin has a certain negative inotropic effect and does not possess...

[Contribution of dynamic isotopic tests in the study of algodystrophies].

Renier JC, Moreau R, Bernat M, Basle M, Jallet P, Minier JF.
PMID: 225781
Rev Rhum Mal Osteoartic. 1979 Apr;46(4):235-41.

The authors studied 20 patients suffering from algodystrophy (23 localizations) by triple scintigraphy with technetium, using pyrophosphate to study the importance of bone changes, marked red blood cells to measure the vascular volume, and pertechnetate to measure the interstitial...

[Plasmacytoma and support therapy with calcitonin].

Adam Z.
PMID: 1796564
Vnitr Lek. 1991 Nov-Dec;37(11):898-900.

The author describes the excellent effect of two-years therapy of a female patient suffering from multiple myeloma, using the calcitonin preparation Miacalcic Sandoz. During the two and a half year follow up of the patient only a small progression...

Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.

Ralston SH, Alzaid AA, Gardner MD, Boyle IT.
PMID: 3087513
Br Med J (Clin Res Ed). 1986 Jun 14;292(6535):1549-50. doi: 10.1136/bmj.292.6535.1549.
Free PMC Article

Eight patients with cancer associated hypercalcaemia were treated with the combination of aminohydroxypropylidene diphosphonate and salmon calcitonin for six days. Serum calcium concentration fell significantly within 24 hours of starting treatment due to a reduction in bone resorption and...

Calcitonin 1975.

Milhaud G.
PMID: 791386
Biomedicine. 1976 Jun;24(3):159-62.

No abstract available.

Calcium metabolism--recent advances.

Raisz LG.
PMID: 4264562
Dis Mon. 1972 Dec;1-56.

No abstract available.

Showing 1 to 12 of 2432 entries